NEW YORK (GenomeWeb News) – Teva Pharmaceutical Industries and the Israeli subsidiary of protein array company Procognia will collaborate on two biopharmaceutical products, the companies said today.
 
Under the agreement, Teva will have exclusive access to Procognia Israel’s glycoanalysis technology and related services.
 
Procognia will receive milestone and royalty payments from Teva, which will finance the collaboration.
 
Additional financial details were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

Jun
19
Sponsored by
ACD

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.